Clinical Trial Update: Korean Multicenter Randomized Controlled Trial (RCT) of Pidogul for Patients With Coronary Stenting [Phase 4]

View source ↗

Summary

Phase 4 multicenter randomized trial evaluating Pidogul in patients with coronary artery disease after coronary stenting has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Pidogul

Snippet

Sponsor: Seoul National University Hospital | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED